The big tau splice isoform resists Alzheimer's-related pathological changes.
Dah-Eun Chloe ChungXue DengHari Krishna YalamanchiliJean-Pierre RevelliAlexander L HanBakhos TadrosRonald RichmanMichelle DiasFatemeh Alavi NainiSteven BoeynaemsBradley T HymanHuda Yaya ZoghbiPublished in: bioRxiv : the preprint server for biology (2024)
In Alzheimer's disease (AD), the microtubule-binding protein tau becomes abnormally hyperphosphorylated and aggregated in selective brain regions such as the cortex and hippocampus 1-3 . However, other brain regions like the cerebellum and brain stem remain largely intact despite the universal expression of tau throughout the brain. Here, we found that an understudied splice isoform of tau termed "big tau" is significantly more abundant in the brain regions less vulnerable to tau pathology compared to tau pathology-vulnerable regions. We used various cellular and animal models to demonstrate that big tau possesses multiple properties that can resist AD-related pathological changes. Importantly, human AD patients show a higher expression level of pathology-resisting big tau in the cerebellum, the brain region spared from tau pathology. Our study examines the unique properties of big tau, expanding our current understanding of tau pathophysiology. Altogether, our data suggest that alternative splicing to favor big tau is a viable strategy to modulate tau pathology.
Keyphrases
- cerebrospinal fluid
- big data
- resting state
- white matter
- binding protein
- functional connectivity
- poor prognosis
- endothelial cells
- chronic kidney disease
- end stage renal disease
- multiple sclerosis
- spinal cord
- spinal cord injury
- prognostic factors
- ejection fraction
- cognitive impairment
- artificial intelligence
- peritoneal dialysis
- deep learning
- data analysis